Topic Hub
4 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 4 of 4 clinical reviews.
A clinical review of dapagliflozin (Farxiga) pharmacokinetics, pharmacogenomics, and ethnicity-stratified trial data relevant to Black and African ancestry patients, including dose adjustment guidance, CKD considerations, and G6PD prevalence.
Read clinical reviewA detailed clinical guide to dapagliflozin (Farxiga) dosing, pharmacogenomics, and ethnicity-stratified trial data for Hispanic and Latino patients with type 2 diabetes, heart failure, or CKD.
Read clinical reviewEvidence-based review of how dapagliflozin safety, pharmacokinetics, and dosing considerations differ in East Asian populations, including Japanese, Chinese, and Korean clinical trial data.
Read clinical reviewEvidence-based review of how dapagliflozin (Farxiga) safety and tolerability differ in Hispanic and Latino populations, including pharmacogenomic factors, trial subgroup data, and clinical monitoring recommendations.
Read clinical review